Cargando…
Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection
We previously showed that in mice infected with Leishmania major type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8 weeks of L. major infection and whether type I...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807663/ https://www.ncbi.nlm.nih.gov/pubmed/29459858 http://dx.doi.org/10.3389/fimmu.2018.00079 |
_version_ | 1783299317402959872 |
---|---|
author | Schleicher, Ulrike Liese, Jan Justies, Nicole Mischke, Thomas Haeberlein, Simone Sebald, Heidi Kalinke, Ulrich Weiss, Siegfried Bogdan, Christian |
author_facet | Schleicher, Ulrike Liese, Jan Justies, Nicole Mischke, Thomas Haeberlein, Simone Sebald, Heidi Kalinke, Ulrich Weiss, Siegfried Bogdan, Christian |
author_sort | Schleicher, Ulrike |
collection | PubMed |
description | We previously showed that in mice infected with Leishmania major type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8 weeks of L. major infection and whether type I IFNs are essential for a protective immune response and clinical cure of the disease. In self-healing C57BL/6 mice infected with a high dose of L. major, IFN-α4, IFN-α5, IFN-α11, IFN-α13, and IFN-β mRNA were most prominently regulated during the course of infection. In C57BL/6 mice deficient for IFN-β or the IFN-α/β-receptor chain 1 (IFNAR1), development of skin lesions and parasite loads in skin, draining lymph node, and spleen was indistinguishable from wild-type (WT) mice. In line with the clinical findings, C57BL/6 IFN-β(−/−), IFNAR1(−/−), and WT mice exhibited similar mRNA expression levels of IFN-γ, interleukin (IL)-4, IL-12, IL-13, inducible nitric oxide synthase, and arginase 1 during the acute and late phase of the infection. Also, myeloid dendritic cells from WT and IFNAR1(−/−) mice produced comparable amounts of IL-12p40/p70 protein upon exposure to L. major in vitro. In non-healing BALB/c WT mice, the mRNAs of IFN-α subtypes (α2, α4, α5, α6, and α9) were rapidly induced after high-dose L. major infection. However, genetic deletion of IFNAR1 or IFN-β did not alter the progressive course of infection seen in WT BALB/c mice. Finally, we tested whether type I IFNs and/or IL-12 are required for the prophylactic effect of CpG-oligodesoxynucleotides (ODN) in BALB/c mice. Local and systemic administration of CpG-ODN 1668 protected WT and IFN-β(−/−) mice equally well from progressive leishmaniasis. By contrast, the protective effect of CpG-ODN 1668 was lost in BALB/c IFNAR1(−/−) (despite a sustained suppression of IL-4) and in BALB/c IL-12p35(−/−) mice. From these data, we conclude that IFN-β and IFNAR1 signaling are dispensable for a curative immune response to L. major in C57BL/6 mice and irrelevant for disease development in BALB/c mice, whereas IL-12 and IFN-α subtypes are essential for the disease prevention by CpG-ODNs in this mouse strain. |
format | Online Article Text |
id | pubmed-5807663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58076632018-02-19 Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection Schleicher, Ulrike Liese, Jan Justies, Nicole Mischke, Thomas Haeberlein, Simone Sebald, Heidi Kalinke, Ulrich Weiss, Siegfried Bogdan, Christian Front Immunol Immunology We previously showed that in mice infected with Leishmania major type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8 weeks of L. major infection and whether type I IFNs are essential for a protective immune response and clinical cure of the disease. In self-healing C57BL/6 mice infected with a high dose of L. major, IFN-α4, IFN-α5, IFN-α11, IFN-α13, and IFN-β mRNA were most prominently regulated during the course of infection. In C57BL/6 mice deficient for IFN-β or the IFN-α/β-receptor chain 1 (IFNAR1), development of skin lesions and parasite loads in skin, draining lymph node, and spleen was indistinguishable from wild-type (WT) mice. In line with the clinical findings, C57BL/6 IFN-β(−/−), IFNAR1(−/−), and WT mice exhibited similar mRNA expression levels of IFN-γ, interleukin (IL)-4, IL-12, IL-13, inducible nitric oxide synthase, and arginase 1 during the acute and late phase of the infection. Also, myeloid dendritic cells from WT and IFNAR1(−/−) mice produced comparable amounts of IL-12p40/p70 protein upon exposure to L. major in vitro. In non-healing BALB/c WT mice, the mRNAs of IFN-α subtypes (α2, α4, α5, α6, and α9) were rapidly induced after high-dose L. major infection. However, genetic deletion of IFNAR1 or IFN-β did not alter the progressive course of infection seen in WT BALB/c mice. Finally, we tested whether type I IFNs and/or IL-12 are required for the prophylactic effect of CpG-oligodesoxynucleotides (ODN) in BALB/c mice. Local and systemic administration of CpG-ODN 1668 protected WT and IFN-β(−/−) mice equally well from progressive leishmaniasis. By contrast, the protective effect of CpG-ODN 1668 was lost in BALB/c IFNAR1(−/−) (despite a sustained suppression of IL-4) and in BALB/c IL-12p35(−/−) mice. From these data, we conclude that IFN-β and IFNAR1 signaling are dispensable for a curative immune response to L. major in C57BL/6 mice and irrelevant for disease development in BALB/c mice, whereas IL-12 and IFN-α subtypes are essential for the disease prevention by CpG-ODNs in this mouse strain. Frontiers Media S.A. 2018-02-05 /pmc/articles/PMC5807663/ /pubmed/29459858 http://dx.doi.org/10.3389/fimmu.2018.00079 Text en Copyright © 2018 Schleicher, Liese, Justies, Mischke, Haeberlein, Sebald, Kalinke, Weiss and Bogdan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Schleicher, Ulrike Liese, Jan Justies, Nicole Mischke, Thomas Haeberlein, Simone Sebald, Heidi Kalinke, Ulrich Weiss, Siegfried Bogdan, Christian Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title | Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title_full | Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title_fullStr | Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title_full_unstemmed | Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title_short | Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection |
title_sort | type i interferon signaling is required for cpg-oligodesoxynucleotide-induced control of leishmania major, but not for spontaneous cure of subcutaneous primary or secondary l. major infection |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807663/ https://www.ncbi.nlm.nih.gov/pubmed/29459858 http://dx.doi.org/10.3389/fimmu.2018.00079 |
work_keys_str_mv | AT schleicherulrike typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT liesejan typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT justiesnicole typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT mischkethomas typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT haeberleinsimone typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT sebaldheidi typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT kalinkeulrich typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT weisssiegfried typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection AT bogdanchristian typeiinterferonsignalingisrequiredforcpgoligodesoxynucleotideinducedcontrolofleishmaniamajorbutnotforspontaneouscureofsubcutaneousprimaryorsecondarylmajorinfection |